Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have been assigned a consensus recommendation of “Hold” from ...

CRSP Stock’s Performance, Valuation & Estimates Shares of CRISPR Therapeutics have plunged nearly 40% in the past year compared with the industry’s 9% decline, as seen in the chart below.

Stock price predictions for 2025 are increasingly "meta." No, not the Facebook parent, but rather the idea that investments are increasingly self-referential rather than reliant on outside or ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched ... trends in earnings estimate revisions and short-term stock price movements. For the current quarter, CRISPR Therapeutics is ...

Analysts at Zacks Research issued their FY2027 earnings per share (EPS) estimates for CRISPR Therapeutics in a report ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...